ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Current Landscape of Pharmacotherapies for Sarcopenia
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 275510" data-attributes="member: 13851"><p><strong><u>Take Home Messages</u></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong><em>*Although many pharmacotherapeutic agents have been studied over the years, there is no approved drug for sarcopenia so far.</em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Complex multifactorial pathogenesis of sarcopenia seems to be the major cause of disappointment encountered in the field of pharmacotherapies for sarcopenia. Novel therapeutics (single or in combination) with more than one potential target of action may finally enable pharmacological prevention or treatment of sarcopenia.</em></strong></p><p><strong><em></em></strong></p><p><em><strong>*Different molecules or pathways may be more prominent in the pathophysiology of age-related sarcopenia and in a variety of secondary sarcopenia subtypes. As in the treatment of many other diseases with complex/multifactorial pathogenesis (e.g., type 2 diabetes mellitus), individualized/tailored pharmacotherapy is expected to come to the fore in the context of sarcopenia in the coming years.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 275510, member: 13851"] [B][U]Take Home Messages[/U] [I]*Although many pharmacotherapeutic agents have been studied over the years, there is no approved drug for sarcopenia so far. *Complex multifactorial pathogenesis of sarcopenia seems to be the major cause of disappointment encountered in the field of pharmacotherapies for sarcopenia. Novel therapeutics (single or in combination) with more than one potential target of action may finally enable pharmacological prevention or treatment of sarcopenia. [/I][/B] [I][B]*Different molecules or pathways may be more prominent in the pathophysiology of age-related sarcopenia and in a variety of secondary sarcopenia subtypes. As in the treatment of many other diseases with complex/multifactorial pathogenesis (e.g., type 2 diabetes mellitus), individualized/tailored pharmacotherapy is expected to come to the fore in the context of sarcopenia in the coming years.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Current Landscape of Pharmacotherapies for Sarcopenia
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top